Skip to content
The El Paso

If Congress starts reviewing licensing deals, diligence gets a documentation problem

If Congress starts reviewing licensing deals, diligence gets a documentation problem
Photo: KVIA ABC-7 · view original

Historically, national security reviews were not a topic of conversation in biotech licensing deals. Things are changing. The bipartisan Biotech Investment National Security Act of 2026 would amend the COINS Act by adding biotechnology as a covered sector, expand reviewable transactions to includ...

Sources and story details